579
Views
8
CrossRef citations to date
0
Altmetric
Standard Articles

When contaminated dietary supplements cause positive drug tests: methylhexaneamine as a doping agent in sport

Pages 677-689 | Received 08 Jan 2017, Accepted 27 Jun 2017, Published online: 07 Jul 2017
 

ABSTRACT

Researchers estimate that contaminated dietary supplements cause between 6.4% and 8.8% of all positive drug tests in competitive sport. Methylhexaneamine (DMAA), an amphetamine derivative banned by the World Anti-Doping Agency (WADA) in 2009, has caused more positive tests than any other stimulant. The current article examines DMAA as a potentially hazardous supplement contaminant and doping agent, beginning with an historical overview. Sections addressing its status as both a performance-enhancing substance and potential health threat follow. The article then situates methylhexaneamine in a sport-policy context, identifying DMAA-related challenges to the effective and uniform enforcement of the WADA Code. A final section offers suggestions for both athletes and athletic organisations.

Disclosure statement

No potential conflict of interest was reported by the author.

Notes

1. Eichner and Tygart (Citation2016, p. 304) defined sport supplements as ‘products marketed for body-building, weight-loss, [and] pre-workout/energy’.

2. In addition to athletes cited in , five minor-league baseball players received 50-game suspensions in August 2010 for positive DMAA tests (MLB.com Citation2010). Also in 2010, British shot putter Rachel Wallander received a 4-month ban (Gibson Citation2011), and in 2012, the International Association of Athletics Federations (IAAF) issued 6-month bans to Portuguese runner Sara Moreira and South Korean sprinter Lim Hee-nam (Associated Press Citation2012a). In 2012, Welsh boxer Enzo Maccarinelli received a 6-month suspension; British boxer Dillian Whyte received a 2-year ban (Ziegler Citation2013) and Major League Baseball suspended Toronto Blue Jays pitching prospect Marcus Stroman for 50 games following a positive DMAA test (Barrs Citation2012). Syrian hurdler Ghfran Almouhamad tested positive for DMAA at the 2012 London Olympics (Associated Press Citation2012b), and Uzbekistani wrestler Soslan Tigiev lost his 2012 Olympic medal after a positive DMAA test (Associated Press Citation2012c). In March 2013, the International Tennis Federation suspended Dimitar Kutrovsky for 15 months after a positive DMAA test (Lattman and Singer Citation2013), and in December 2013, boxing officials announced that Brandon Rios had tested positive for DMAA following his 23 November loss to Manny Pacquiao (Smith Citation2013). In November 2014, Minnesota Twins catching prospect Alex Real received a 50-game suspension (Associated Press Citation2014), and at the 2014 Sochi Winter Olympics, bobsledder William Frullani, biathlete Evi Sachenbacher-Stehle and hockey player Vitalijs Pavlovs each tested positive for DMAA. Finally, in January 2016, the Confederation of African football suspended Algerian footballer Kheiredine Merzougi for 2 years, which the Federation Internationale de Football Association (FIFA) extended to 4 years (ESPN Citation2016).

4. Travis T. Tygart, CEO of USADA, stated the following as part of the U.S. Department of Justice (Citation2015) indictment announcement: ‘We work to educate athletes on the risks associated with choosing to use supplements, and we will continue to support further action at a national level to prevent dangerous substances and products from being allowed in the marketplace where they can easily be attained by unsuspecting athletes and other consumers.’

5. More recently, Hi-Tech sued Dr. Pieter Cohen, a supplement critic and assistant professor in the Harvard School of Medicine, for allegedly defaming Hi-Tech in an article (Cohen et al. Citation2015) that located an amphetamine isomer, β-methylphenylethylamine (BMPEA), in multiple weight-loss products. Hi-Tech lost the case (Robbins Citation2017). Cohen et al. (Citation2014) also identified methamphetamine analogue N,α-diethyl-phenylethylamine (N,α-DEPEA) as a supplement contaminant.

Additional information

Notes on contributors

Bryan E. Denham

Bryan E. Denham is a professor in the Department of Communication at Clemson University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.